GlassScriptPhysician profile
Rostam Khoshsar
NPI 1336275007
$31,817.81
in general payments reported to CMS, 2019-2025
30 companies · $1,128 in 2025
The $1,128 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,804 · 2020: $2,134 · 2021: $1,451 · 2022: $6,371 · 2023: $6,142 · 2024: $8,788 · 2025: $1,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,983 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,625 · Consulting Fee: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,983.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,625.00 |
| Consulting Fee | $1,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,912.14 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Medtronic, INC. | $5,093.41 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Nevro Corp. | $2,711.83 | 2019-2021 | |
| Surgentec | $2,157.99 | 2022 | |
| Medtronic USA, INC. | $1,934.59 | 2019-2020 | |
| Abbott Laboratories | $1,227.60 | 2019-2023 | Proclaim |
| Painteq LLC | $1,085.17 | 2022-2023 | Painteq |
| Elliquence, LLC | $1,000.00 | 2024 | |
| Spinal Simplicity, LLC | $701.04 | 2022-2023 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $306.51 | 2021-2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $263.19 | 2023-2024 | Prospera, Biotronik |
| Vertiflex, INC. | $249.63 | 2019 | |
| Relievant Medsystems, INC. | $244.19 | 2023 | Intracept |
| Stryker Corporation | $166.50 | 2019 | |
| Spr Therapeutics, INC | $108.00 | 2019-2025 | Sprint Pns System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $100.94 | 2022-2023 | |
| Allergan, INC. | $70.11 | 2021-2022 | |
| Curonix LLC | $67.42 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $62.52 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.15 | 2022 | |
| Electronic Waveform Lab, INC. | $49.05 | 2022 | |
| Vertos Medical, INC. | $43.35 | 2019-2022 | |
| Xtant Medical INC | $43.10 | 2025 | |
| Globus Medical, INC. | $31.84 | 2025 | Senza |
| Neurometrix INC | $30.72 | 2023 | |
| Si-Bone, INC. | $25.83 | 2024 | |
| Scilex Pharmaceuticals INC. | $24.47 | 2023 | Ztlido |
| Valinor Pharma, LLC | $21.63 | 2023 | Movantik |
| Stimwave Technologies Incorporated | $20.00 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rostam Khoshsar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.